These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Differential immunoreactivity of epidermal growth factor receptor in benign, dysplastic and malignant prostatic tissues. Ibrahim GK; Kerns BJ; MacDonald JA; Ibrahim SN; Kinney RB; Humphrey PA; Robertson CN J Urol; 1993 Jan; 149(1):170-3. PubMed ID: 7678041 [TBL] [Abstract][Full Text] [Related]
3. The localization of transforming growth factor alpha and epidermal growth factor receptor in stromal and epithelial compartments of developing human prostate and hyperplastic, dysplastic, and carcinomatous lesions. Leav I; McNeal JE; Ziar J; Alroy J Hum Pathol; 1998 Jul; 29(7):668-75. PubMed ID: 9670822 [TBL] [Abstract][Full Text] [Related]
4. Expression of transforming growth factor-alpha and the epidermal growth factor receptor in human prostate tissues. Cohen DW; Simak R; Fair WR; Melamed J; Scher HI; Cordon-Cardo C J Urol; 1994 Dec; 152(6 Pt 1):2120-4. PubMed ID: 7525998 [TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of epidermal growth factor receptor gene expression and protein product in benign, premalignant, and malignant prostate tissue. Turkeri LN; Sakr WA; Wykes SM; Grignon DJ; Pontes JE; Macoska JA Prostate; 1994 Oct; 25(4):199-205. PubMed ID: 7521960 [TBL] [Abstract][Full Text] [Related]
6. Expression of androgen receptor and growth factors in premalignant lesions of the prostate. Harper ME; Glynne-Jones E; Goddard L; Mathews P; Nicholson RI J Pathol; 1998 Oct; 186(2):169-77. PubMed ID: 9924433 [TBL] [Abstract][Full Text] [Related]
7. Expression of the VEGF-receptor Flt-1 in benign, premalignant and malignant prostate tissues. Hahn D; Simak R; Steiner GE; Handisurya A; Susani M; Marberger M J Urol; 2000 Aug; 164(2):506-10. PubMed ID: 10893635 [TBL] [Abstract][Full Text] [Related]
8. Expression of mRNA for epidermal growth factor, transforming growth factor-alpha and their receptor in human prostate tissue and cell lines. Ching KZ; Ramsey E; Pettigrew N; D'Cunha R; Jason M; Dodd JG Mol Cell Biochem; 1993 Sep; 126(2):151-8. PubMed ID: 7508078 [TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor beta 1 and its receptor types I and II. Comparison in human normal prostate, benign prostatic hyperplasia, and prostatic carcinoma. Royuela M; De Miguel MP; Bethencourt FR; Sanchez-Chapado M; Fraile B; Paniagua R Growth Factors; 1998; 16(2):101-10. PubMed ID: 9932228 [TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical comparative analysis of transforming growth factor alpha, epidermal growth factor, and epidermal growth factor receptor in normal, hyperplastic and neoplastic human prostates. De Miguel P; Royuela ; Bethencourt R; Ruiz A; Fraile B; Paniagua R Cytokine; 1999 Sep; 11(9):722-7. PubMed ID: 10479409 [TBL] [Abstract][Full Text] [Related]
11. Differential immunoreactivity of her-2/neu oncoprotein in prostatic tissues. Ibrahim GK; MacDonald JA; Kerns BJ; Ibrahim SN; Humphrey PA; Robertson CN Surg Oncol; 1992 Apr; 1(2):151-5. PubMed ID: 1285216 [TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor beta 1 and androgen receptors in prostate neoplasia. Cardillo MR; Petrangeli E; Salvatori L; Ravenna L; Di Silverio F Anal Quant Cytol Histol; 2000 Oct; 22(5):403-10. PubMed ID: 11064817 [TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical study of the expression of epidermal growth factor receptor in benign prostatic hypertrophy, prostatic intraepithelial neoplasia and prostatic carcinoma. Rana S; Sen R; Kalra R; Arora B; Sharma P; Gahlawat S Indian J Pathol Microbiol; 2006 Oct; 49(4):495-9. PubMed ID: 17183836 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of cytokeratin markers to differentiate between benign and malignant prostatic tissue. Guinan P; Shaw M; Targonski P; Ray V; Rubenstein M J Surg Oncol; 1989 Nov; 42(3):175-80. PubMed ID: 2478835 [TBL] [Abstract][Full Text] [Related]
16. Expression of proinflammatory cytokine interleukin-6 in tissue samples of human prostate obtained by needle biopsy. Miličević N; Mrčela M; Galić J; Marjanović K Pathol Res Pract; 2015 Nov; 211(11):865-70. PubMed ID: 26376467 [TBL] [Abstract][Full Text] [Related]
17. Expression of c-kit and kit-ligand in benign and malignant prostatic tissues. Simak R; Capodieci P; Cohen DW; Fair WR; Scher H; Melamed J; Drobnjak M; Heston WD; Stix U; Steiner G; Cordon-Cardo C Histol Histopathol; 2000 Apr; 15(2):365-74. PubMed ID: 10809354 [TBL] [Abstract][Full Text] [Related]
18. Expression of transforming growth factor-alpha, epidermal growth factor and the epidermal growth factor receptor in adenocarcinoma of the prostate and benign prostatic hyperplasia. Myers RB; Kudlow JE; Grizzle WE Mod Pathol; 1993 Nov; 6(6):733-7. PubMed ID: 7508115 [TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of mRNA and protein expression for epidermal growth factor receptor and ligands relative to the proliferative index in human prostate tissue. Glynne-Jones E; Goddard L; Harper ME Hum Pathol; 1996 Jul; 27(7):688-94. PubMed ID: 8698313 [TBL] [Abstract][Full Text] [Related]
20. Localization of epidermal growth factor receptor by immunohistochemical methods in human prostatic carcinoma, prostatic intraepithelial neoplasia, and benign hyperplasia. Maygarden SJ; Strom S; Ware JL Arch Pathol Lab Med; 1992 Mar; 116(3):269-73. PubMed ID: 1371380 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]